CRISPR Therapeutics Vertex Pharmaceuticals: Better Buy in 2026
Investors face a choice between a high-growth gene-editing bet and a cash-generating biotech leader. This article bre...
What Happens To Index Funds During Recession: Historically, broad market indices may drop, but diversified funds can recover faster as economies stabilize.
20,267 articlesInvestors face a choice between a high-growth gene-editing bet and a cash-generating biotech leader. This article bre...
Looking for legitimate ways to monetize a few spare minutes? Apps for online surveys that pay let you turn quick poll...
Investors often wonder if a smaller company can replicate Berkshire Hathaway’s long-term success. This analysis looks...
Bloom Energy has sprinted higher this year on an AI-powered energy story. As a late entrant, you’ll want a clear view...
A single credential from the US government sent Tenable stock racing higher. This article breaks down the catalyst, t...
A Jersey Republican is set to reappear in Congress after nearly four months away, citing an unspecified medical condi...
AI-generated listing videos are reshaping real estate marketing, but new disclosures aim to curb misrepresentation. T...
A July 2026 mid-year review spots Coca-Cola, Procter & Gamble, and Johnson & Johnson as the leading dividend aristocr...
A public figure’s passing highlights how royalties, catalogs, and estate planning shape financial security. This arti...
XRP’s derivatives market shows a rare drop in open interest while large holders accumulate on-chain. The move could h...
In June, Lemonade stock surged about 12% as investors weighed progress on its reinsurance strategy and AI-driven grow...
A surge in AI workloads hinges on memory, and Micron’s latest signals hint at lasting strength. This piece unpacks wh...